Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000238777 | SCV000297087 | uncertain significance | not specified | 2015-08-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705318 | SCV000512576 | benign | not provided | 2020-01-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000469639 | SCV000553255 | likely benign | Developmental and epileptic encephalopathy 94 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001705318 | SCV002063453 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | CHD2: BS1 |
Ambry Genetics | RCV002338790 | SCV002644363 | likely benign | Inborn genetic diseases | 2021-10-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |